← Back to Directory

SARS-CoV-2

The premium Open Source alternative to Benchling

🎯 Best for:Academic researchers in virology
Visit WebsiteCompare with Benchling
0.0k
Stars
MITLicense

What is SARS-CoV-2?

Replaces closed-source bioinformatics pipelines for viral therapy research. Uses computational RNAi-based therapy candidate discovery via genomic sequence analysis.

Tech Stack
PythonBiology & Biotechnology

Why SARS-CoV-2?

  • • High scientific transparency
  • • Specialized RNAi logic
  • • Reproducible research scripts

Limitations

  • • Requires domain expertise
  • • CLI-heavy interface
  • • High compute requirements
12/18/2020
Last Update
0
Forks
0
Issues
MIT
License
Financial Leak Detected

Stop the "SaaS Tax"

Your team could be burning cash. Switching to SARS-CoV-2 instantly boosts your runway.

Competitor Cost
-$1,440
/ year (est. based on Benchling)
Self-Hosted
$0
/ year
Team Size10 Users
150+
Launch Detailed Calculator
SAVE 100%

Community Discussion

Comments